Skip to main content

Table 1 Presenting features of 404 ART naïve adults in care at Themba Lethu in Johannesburg, South Africa stratified by KSHV&status

From: Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa

Characteristics#   * General Clinic Population (n = 679) KSHV+&(n = 193) KSHV-&(n = 211)
Female   416 (61%) 127 (66%) 135 (64%)
Age (yrs.) Median (IQR) 37 (31-43) 37 (32-47) 38 (32-45)
WHO Stage I/II 408 (64%) 116 (64%) 114 (61%)
(n, %) III/IV 231 (36%) 64 (36%) 74 (39%)
BMI < 18.5 118 (23%) 38 (21%) 57 (29%)
(n, %) 18.5-24.9 286 (56%) 98 (56%) 94 (48%)
  25-30 72 (14%) 23 (13%) 31 (16%)
  > 30 37 (7%) 15 (8%) 14 (7%)
Hemoglobin (n, %) ≤ 8.0 g/dL 41 (7%) 14 (7%) 13 (6%)
CD4 count (cells/mm3) Median (IQR) 100 (39-173) 101 (46-168) 89 (34-164)
CD4 cell count category 0-50 167 (31%) 47 (28%) 63 (34%)
(n, %) 51-100 106 (19%) 39 (23%) 39 (21%)
  101-200 182 (33%) 65 (38%) 56 (30%)
  200-350 89 (16%) 20 (12%) 30 (16%)
Tuberculosis (n, %) Yes 75 (11%) 26 (14%) 30 (15%)
HIV RNA Median (IQR) 20000 (8300-39000) 15500 (6400-33500) 19500 (7300-39000)
  1. # Characteristics at eligibility for initiation of antiretroviral therapy
  2. * Themba Lethu clinic general population refers to treatment naïve adults eligible for initiation of antiretroviral therapy during the study period who were not recruited into the study
  3. &KSHV = Kaposi sarcoma herpes virus